Status:
COMPLETED
Effect of PF-00734200 in Subjects With Type 2 Diabetes
Lead Sponsor:
Pfizer
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
18-80 years
Phase:
PHASE2
Brief Summary
To determine the effect of PF-00734200 on HbA1c in type 2 diabetic subjects receiving metformin
Eligibility Criteria
Inclusion
- Men or women between 18-80 years of age with poorly controlled Type 2 diabetes
Exclusion
- Type 1 or secondary forms of diabetes Currently using insulin
Key Trial Info
Start Date :
February 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2008
Estimated Enrollment :
289 Patients enrolled
Trial Details
Trial ID
NCT00618007
Start Date
February 1 2008
End Date
August 1 2008
Last Update
June 27 2011
Active Locations (79)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Birmingham, Alabama, United States, 35205
2
Pfizer Investigational Site
Chandler, Arizona, United States, 85225
3
Pfizer Investigational Site
Litchfield Park, Arizona, United States, 85340
4
Pfizer Investigational Site
Phoenix, Arizona, United States, 85051